SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-062103
Filing Date
2018-10-15
Accepted
2018-10-15 16:18:01
Documents
33
Period of Report
2018-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q a18-19064_110q.htm 10-Q 346026
2 EX-31.1 a18-19064_1ex31d1.htm EX-31.1 10824
3 EX-31.2 a18-19064_1ex31d2.htm EX-31.2 10796
4 EX-32.1 a18-19064_1ex32d1.htm EX-32.1 6287
5 EX-32.2 a18-19064_1ex32d2.htm EX-32.2 6262
  Complete submission text file 0001104659-18-062103.txt   1365330

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bzyr-20180831.xml EX-101.INS 200718
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bzyr-20180831.xsd EX-101.SCH 14789
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bzyr-20180831_cal.xml EX-101.CAL 15648
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bzyr-20180831_def.xml EX-101.DEF 32378
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bzyr-20180831_lab.xml EX-101.LAB 137551
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bzyr-20180831_pre.xml EX-101.PRE 85082
Mailing Address
Business Address 12000 RICHMOND AVE HOUSTON TX 77082
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

IRS No.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-23425 | Film No.: 181122403
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1